- Investing Ideas
- /
- Software Healthcare Sector
Software Healthcare Sector
Results
2311
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,311 companies
Protagonist Therapeutics
Market Cap: US$2.7b
A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.
PTGX
US$42.97
7D
-5.6%
1Y
52.2%
Xenon Pharmaceuticals
Market Cap: US$2.7b
A neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada.
XENE
US$35.02
7D
-8.5%
1Y
-13.6%
Concentra Group Holdings Parent
Market Cap: US$2.7b
Provides occupational health services in the United States.
CON
US$21.40
7D
-1.7%
1Y
n/a
Metsera
Market Cap: US$2.6b
A clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases.
MTSR
US$23.87
7D
-6.9%
1Y
n/a
HUTCHMED (China)
Market Cap: UK£1.9b
HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.
HCM
UK£2.28
7D
-1.9%
1Y
-35.2%
MoonLake Immunotherapeutics
Market Cap: US$2.5b
A clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases.
MLTX
US$38.47
7D
-9.1%
1Y
-6.0%
QuidelOrtho
Market Cap: US$2.5b
Provides diagnostic testing solutions.
QDEL
US$36.34
7D
24.8%
1Y
-14.7%
Veracyte
Market Cap: US$2.4b
Operates as a diagnostics company in the United States and internationally.
VCYT
US$29.71
7D
-2.1%
1Y
39.0%
Immunovant
Market Cap: US$2.4b
A clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases.
IMVT
US$14.02
7D
-11.3%
1Y
-52.3%
LivaNova
Market Cap: US$2.4b
A medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide.
LIVN
US$44.06
7D
19.8%
1Y
-29.0%
Organon
Market Cap: US$2.3b
Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.
OGN
US$8.71
7D
-9.2%
1Y
-57.3%
Amneal Pharmaceuticals
Market Cap: US$2.3b
A global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide.
AMRX
US$7.41
7D
-7.0%
1Y
11.3%
LifeStance Health Group
Market Cap: US$2.3b
Through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States.
LFST
US$5.73
7D
-15.7%
1Y
-16.5%
Acadia Healthcare Company
Market Cap: US$2.2b
Provides behavioral healthcare services in the United States and Puerto Rico.
ACHC
US$23.84
7D
2.3%
1Y
-66.8%
Apogee Therapeutics
Market Cap: US$2.2b
A clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other inflammatory and immunology indications.
APGE
US$37.29
7D
-7.1%
1Y
-29.9%
Mirum Pharmaceuticals
Market Cap: US$2.2b
A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.
MIRM
US$44.27
7D
1.3%
1Y
78.8%
Apellis Pharmaceuticals
Market Cap: US$2.2b
A commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs.
APLS
US$17.30
7D
-14.9%
1Y
-58.8%
Vericel
Market Cap: US$2.1b
A commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America.
VCEL
US$41.73
7D
7.1%
1Y
-13.2%
Denali Therapeutics
Market Cap: US$2.1b
A biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases.
DNLI
US$14.37
7D
-12.6%
1Y
-21.5%
Ardent Health Partners
Market Cap: US$2.1b
Owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States.
ARDT
US$14.52
7D
10.3%
1Y
n/a
BioCryst Pharmaceuticals
Market Cap: US$2.1b
A biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases.
BCRX
US$9.97
7D
11.6%
1Y
87.4%
Biohaven
Market Cap: US$2.1b
Biohaven Ltd. discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology worldwide.
BHVN
US$20.24
7D
-11.4%
1Y
-43.3%
NewAmsterdam Pharma
Market Cap: US$2.1b
A late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease.
NAMS
US$18.37
7D
-8.3%
1Y
-14.3%
Addus HomeCare
Market Cap: US$2.0b
Provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States.
ADUS
US$110.91
7D
5.6%
1Y
1.5%
Progyny
Market Cap: US$2.0b
A benefits management company, provides fertility, family building, and women’s health benefits solutions in the United States.
PGNY
US$21.19
7D
-8.8%
1Y
-23.0%
Kymera Therapeutics
Market Cap: US$2.0b
A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.
KYMR
US$30.07
7D
-14.8%
1Y
-20.7%
Ligand Pharmaceuticals
Market Cap: US$2.0b
A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.
LGND
US$104.48
7D
-4.5%
1Y
19.7%
Belite Bio
Market Cap: US$2.0b
A clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medical needs in the United States.
BLTE
US$61.10
7D
-2.5%
1Y
45.3%
SS Innovations International
Market Cap: US$2.0b
Operates as a commercial-stage surgical robotics company in India and internationally.
SSII
US$10.09
7D
-4.0%
1Y
137.4%
Harmony Biosciences Holdings
Market Cap: US$2.0b
A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.
HRMY
US$34.05
7D
12.3%
1Y
13.0%
Twist Bioscience
Market Cap: US$2.0b
Manufactures and sells synthetic DNA-based products.
TWST
US$30.82
7D
-21.5%
1Y
-27.3%
Kiniksa Pharmaceuticals International
Market Cap: US$1.9b
A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.
KNSA
US$26.03
7D
-5.9%
1Y
33.3%
NovoCure
Market Cap: US$1.9b
An oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally.
NVCR
US$17.38
7D
-4.2%
1Y
5.5%
Certara
Market Cap: US$1.9b
Provides technology-enabled services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally.
CERT
US$11.98
7D
-7.8%
1Y
-29.5%
Premier
Market Cap: US$1.9b
Operates as a healthcare improvement company in the United States.
PINC
US$23.07
7D
12.8%
1Y
18.3%
Clover Health Investments
Market Cap: US$1.9b
Provides medicare advantage plans in the United States.
CLOV
US$3.51
7D
5.1%
1Y
328.0%